Pharmafile Logo

News and Press Releases

Celonic Group and CARBOGEN AMCIS Announce Strategic Alliance to Deliver Fully Integrated ADC Development and Manufacturing Platform

7 October 2025 -- Basel, Switzerland -- CELONIC GROUP, one of the leading “pureplay” Biologics CDMO, and the Carbogen Amcis Group, a leading pharmaceutical process development and Active Pharmaceutical Ingredient (API)...

Category: BioManufacturing, Clinical Trials, Manufacturing and Packing, Other, Pharmaceutical
Posted: October 7, 2025

CARBOGEN AMCIS
info@carbogen-amcis.com
Hauptstrasse 171 CH-4416 Bubendorf Switzerland

Celonic Inaugurates “Next Generation” Biologics Development Centre (BDC) and Pilot Plant in Basel, Switzerland

The Celonic Group, a “Pure Play” Biologics contract development and manufacturing organisation (CDMO), expands process development and optimisation services in Basel Investment builds on “Next Generation” bioprocessing capability and pilot...

Category: BioManufacturing, Pharmaceutical
Posted: June 18, 2024

Celonic
Elisa.Witt@celonic.com
Eulerstrasse 55 CH - 4051 Basel

Celonic Launches New GS-CHOvolution Cell Line Expression System

GS-CHOvolution is based on Revvity’s CHOSOURCE expression platform and TnT transposon technology 8 April 2024 -- Basel, Switzerland -- Celonic has signed a commercial license agreement with Revvity for its CHOSOURCE...

Category: BioManufacturing
Posted: April 8, 2024

Celonic
Elisa.Witt@celonic.com
Eulerstrasse 55 CH - 4051 Basel

Revvity Signals Software Introduces Signals ChemDraw Offering to Set New Standard for Cloud-Native Chemistry Communication

 Next-generation suite enhances research productivity and innovation across chemical, pharmaceutical and biotechnology industries and academia Seamless integration within Revvity Signals Research platform empowers multidisciplinary discoveries. 18 March 2024 -- Massachusetts,...

Category: Biotechnology
Posted: March 18, 2024

Revvity
Ruixin.Zhu@revvity.com
940 Winter St, Waltham, MA, United States